Ignite Creation Date:
2025-12-25 @ 4:35 AM
Ignite Modification Date:
2025-12-26 @ 3:37 AM
Study NCT ID:
NCT05627518
Status:
COMPLETED
Last Update Posted:
2025-04-03
First Post:
2022-11-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation
Sponsor:
Cinclus Pharma Holding AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-16
First Submit QC Date:
None
Study First Post Date:
2022-11-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-16
Results First Submit QC Date:
None
Results First Post Date:
2025-04-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-17
Last Update Post Date:
2025-04-03
Last Update Post Date Type:
ACTUAL